|
Steroid-sparing therapy is promising for allergic asthma
Skin and Allergy News Digital Network KEYSTONE, COLO. – A novel toll-like receptor-9 agonist showed impressive clinical efficacy in persistent allergic asthma in a double-blind, placebo-controlled clinical trial. "This is really interesting," Dr. Harold S. Nelson commented in highlighting … |
View full post on asthma – Google News